Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.56 |
| ▸ | RARB | P10826 | 8/20 | 0.53 |
| ▸ | RARA | P10276 | 1/20 | 0.53 |
| ▸ | RARG | P13631 | 1/20 | 0.53 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | PTAFR | P25105 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1817958 | 0.90 | TAAR1 (0.63) | TAAR1RARBRARARARGMGLL | |
| SCHEMBL3172562 | 0.90 | RARB (0.46) | TAAR1RARBRARARARGMGLL | |
| SCHEMBL10030230 | 0.89 | RARB (0.56) | TAAR1RARBRARARARGCYP3A4 | |
| SCHEMBL3158112 | 0.89 | RARB (0.48) | TAAR1RARBRARARARGMGLL | |
| SCHEMBL3159462 | 0.89 | RARB (0.48) | TAAR1RARBRARARARGMGLL | |
| SCHEMBL7786181 | 0.89 | TAAR1 (0.61) | TAAR1RARBRARARARGMGLL | |
| SCHEMBL2909950 | 0.87 | RARB (0.64) | RARBRARARARGHSD11B1TSHR | |
| SCHEMBL1816914 | 0.87 | RARB (0.57) | TAAR1RARBRARARARGCYP3A4 | |
| SCHEMBL14175167 | 0.87 | RARB (0.66) | RARBRARARARGCYP3A4TSHR | |
| SCHEMBL30967305 | 0.86 | TAAR1 (0.58) | TAAR1RARBRARARARGCYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372975-B2 | Liquid crystal compound having difluoropropenyleneoxy bonding group | JNC CORPORATION (JP) | 2013-02-12 | — | — | US | disclosed |
| US-8372975-B2 | Liquid crystal compound having difluoropropenyleneoxy bonding group | JNC CORPORATION (JP) | 2013-02-12 | — | — | US | disclosed |
| US-20120029194-A1 | LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP | CHISSO PETROCHEMICAL CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120029194-A1 | LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP | CHISSO PETROCHEMICAL CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-7951433-B2 | Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20100127211-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CF20 BONDING GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100127211-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CF20 BONDING GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CFAP20, KIF20A, KIF20B | TAAR1 3234/4885RARB 2364/4885RARA 1623/4885 |
| US-20120029194-A1 | LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP | LEF1, EIF4A3, TCF4 | TAAR1 3110/4885RARB 3142/4885RARA 2088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.